<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cardiothorac Surg</journal-id><journal-id journal-id-type="iso-abbrev">J Cardiothorac Surg</journal-id><journal-title-group><journal-title>Journal of Cardiothoracic Surgery</journal-title></journal-title-group><issn pub-type="epub">1749-8090</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23020939</article-id><article-id pub-id-type="pmc">3493291</article-id><article-id pub-id-type="publisher-id">1749-8090-7-98</article-id><article-id pub-id-type="doi">10.1186/1749-8090-7-98</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Intravenous flurbiprofen for post-thymectomy pain relief in patients with myasthenia gravis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="A1"><name><surname>Su</surname><given-names>Chunhua</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Kitten_sch@163.com</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Su</surname><given-names>Yihua</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>13822288800@139.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Chou</surname><given-names>Chiu-Wen</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>chiuwen.chou@gmail.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Liu</surname><given-names>Weibing</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>ranliuz@163.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Zou</surname><given-names>Jianyong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>monkeytong1@yahoo.com.cn</email></contrib><contrib contrib-type="author" corresp="yes" id="A6"><name><surname>Luo</surname><given-names>Honghe</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>luohhzm@163.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A7"><name><surname>Chen</surname><given-names>Zhenguang</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I5">5</xref><email>chenzhenguang@yahoo.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Thoracic Surgery Lung Cancer Research Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan Road 2, Guangzhou, Guangdong, 510080, People&#x02019;s Republic of China</aff><aff id="I2"><label>2</label>Department of Ophthalmology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, People&#x02019;s Republic of China</aff><aff id="I3"><label>3</label>Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, People&#x02019;s Republic of China</aff><aff id="I4"><label>4</label>Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, People&#x02019;s Republic of China</aff><aff id="I5"><label>5</label>Department of Cardiothoracic Surgery in Huangpu Division, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan Road 2, Guangzhou, Guangdong, 510080, People&#x02019;s Republic of China</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>29</day><month>9</month><year>2012</year></pub-date><volume>7</volume><fpage>98</fpage><lpage>98</lpage><history><date date-type="received"><day>9</day><month>2</month><year>2012</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Su et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Su et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.cardiothoracicsurgery.org/content/7/1/98"/><abstract><sec><title>Background</title><p>Post-thymectomy pain in myasthenia gravis (MG) patients can inhibit breathing and coughing. Inappropriate usage of analgesics may exacerbate respiratory inhibition and even cause myasthenic crisis. Flurbiprofen is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used to control moderate postoperative pain and is not associated with respiratory inhibition. We hypothesized that flurbiprofen may provide post-thymectomy pain relief without increasing the risk of complications in MG patients.</p></sec><sec><title>Methods</title><p>Two hundred MG patients underwent extended thymectomy from March 2006 to December 2010 and were randomly allocated to a flurbiprofen group (110 patients, 50 mg intravenous flurbiprofen axetil) or a control group (90 patients, 100 mg intramuscular tramadol) as postoperative analgesia. Visual analog scale (VAS) pain score, heart rate, blood pressure, respiratory rate, pulse oximetry (SpO<sub>2</sub>), and adverse effects were recorded before and up to 24 h after drug administration.</p></sec><sec><title>Results</title><p>There were no significant differences in the preoperative clinical characteristics of the flurbiprofen and control (tramadol) groups. Both flurbiprofen and tramadol significantly alleviated post-thymectomy pain (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 for both), but patients in flurbiprofen group had significantly lower VAS pain scores at 0.5 h, 2 h, 4 h, and 8 h after surgery (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 for all times). There were no significant post-thymectomy changes of heart rate, respiratory rate, mean arterial blood pressure, or SpO<sub>2</sub> in either group at all time points.</p></sec><sec><title>Conclusions</title><p>Post-thymectomy intravenous administration of flurbiprofen axetil provides safe and effective analgesia for MG patients.</p></sec></abstract><kwd-group><kwd>Myasthenia gravis</kwd><kwd>Thymectomy</kwd><kwd>Postoperative care</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Myasthenia gravis (MG) is an autoimmune disorder characterized by progressive muscle fatigue due to alterations of the postsynaptic neuromuscular junction. Most patients also experience abnormalities of the thymus gland, such as thymoma or benign thymus hyperplasia [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Thymectomy in the early stages of MG often improves the overall prognosis [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. The extended transsternal thymectomy is believed as a routine and complete surgical dissection procedure [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B9">9</xref>], and video-assisted thoracic surgery (VATS) thymectomy and robotic-aided video-assisted thoracoscopic thymectomy are continually being developed [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Based on series of 5-year follow-up data, combined cervical and bilateral videoscopic thymectomy and the combined transcervical&#x02013;transsternal thymectomy have 51 and 50%, respectively, remission rates at that interval. Similarly, extended transsternal thymectomy has 40% remission rate and a high percentage of patients with ocular or mild preoperative MG manifestations [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. It suggests that at the extended or combined transcervical transsternal thymectomy have the better remission rates and the outcomes of different minimally invasive approach are still in the investigative phase. Considering that the extended transsternal thymectomy is conventional until now, the management of postoperative pain is often a significant problem in MG patients who have undergone thymectomy via median sternotomy incision [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Surgical pain following thymectomy may disrupt breathing and inhibit coughing, and thus may hamper patient recovery and even lead to myasthenic crisis [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>].</p><p>The choice of analgesic agent and route of administration are important because post-thymectomy pain may compromise pulmonary function, and hypersensitivity to an analgesic agent may induce respiratory depression. Previous research reported good results with high thoracic (C<sub>7</sub>T<sub>1-3</sub>) epidural combinations of bupivacaine and morphine in a small number of patients, but the paucity of such cases and the technical difficulties associated with administration of thoracic epidural analgesia have prevented acceptance of this technique [<xref ref-type="bibr" rid="B18">18</xref>]. However, there are few established analgesics for treatment of post-thymectomy pain in these patients. Traditional analgesics, such as tramadol, may cause severe nausea and vomiting, and inhibit respiration [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. All analgesics must be used with care in post-thymectomy patients with MG [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Non-steroidal anti-inflammatory drugs (NSAIDs) also provide relief from pain after different types of surgery [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Flurbiprofen is an NSAID that can safely and effectively control moderate postoperative pain [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. A recent Cochrane review reported that oral flurbiprofen at a dose of 50 mg or 100 mg provided at least 50% pain relief in 65% to 70% of postoperative patients and only had a weak inhibitory effect on respiration [<xref ref-type="bibr" rid="B25">25</xref>]. Systemic flurbiprofen given as treatment for postoperative pain following thoracotomy reduces serum levels of IL-6 and CRP and appears to contribute to the attenuation of the postoperative inflammatory response and prevent postoperative pain [<xref ref-type="bibr" rid="B26">26</xref>]. However, the effect of intravenous flurbiprofen on post-thymectomy pain relief in patients with MG has not been established.</p><p>In the present study, we investigated the effect of intravenous flurbiprofen on relief from post-thymectomy pain in patients with MG.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patient data</title><p>MG patients who underwent extended thymectomy in the Department of Thoracic Surgery of the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) from March 2007 to December 2010 were enrolled. Clinical information was obtained by review of the preoperative and perioperative medical records. MG was diagnosed based on patient history, clinical symptoms, chest computed tomography, positive response to the edrophonium chloride test, and positive findings by single-fiber electromyography and was staged by criteria of the MG Foundation of America [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Anticholinesterase agents were administered by neurology consultants, and none of the patients received immunosuppressive agents preoperatively. All patients underwent extended thymectomy via median sternotomy followed by standard wound closure, as described previously [<xref ref-type="bibr" rid="B29">29</xref>]. Patients were randomly assigned to the flurbiprofen group (50 mg intravenous flurbiprofen axetil diluted in 0.9% sodium chloride, completed within 1 h) or to the control group (100 mg intramuscular tramadol) for postoperative analgesia. The duration of surgery, time of chest drainage, MGFA stage at 72 h after operation, presence of myasthenia crisis, and adverse reactions were recorded. The hospital ethics committee approved the study protocol (No. 2012&#x02013;038).</p></sec><sec><title>Evaluation of the postoperative pain</title><p>A self-reported visual analog scale (VAS) was used to evaluate postoperative pain, in which 0 indicated &#x0201c;no pain&#x0201d;, 1 to 3 indicated &#x0201c;mild pain&#x0201d;, 4 to 6 indicated &#x0201c;moderate pain&#x0201d;, and 7 to 10 indicated &#x0201c;severe pain&#x0201d;. The severity of nausea and vomiting was recorded with a four-point scale in which 0 indicated &#x0201c;no nausea or vomiting&#x0201d;, 1 indicated &#x0201c;no nausea at rest or nausea with mild vomiting on exertion&#x0201d;, 2 indicated &#x0201c;intermittent nausea at rest or nausea with moderate vomiting on exertion, and 3 indicated &#x0201c;persistent nausea at rest or severe nausea with severe vomiting on exertion&#x0201d;. Mean arterial blood pressure, heart rate, respiratory rate, and SpO<sub>2</sub>, were recorded before surgery and at 0.5 h, 2 h, 4 h, 8 h, and 24 h after administration of analgesics. A myasthenic crisis was defined as respiratory failure caused by respiratory muscle weakness. Adverse events, including gastrointestinal bleeding, ulcers, dizziness, lethargy, flushing, itching, urinary retention, constipation, respiratory inhibition, abnormal bleeding, were also recorded. Nausea and vomiting were treated with 10 mg of intramuscular metoclopramide, and headache was treated with 60 mg of intramuscular rotundine.</p></sec><sec><title>Statistical analysis</title><p>All statistical calculations were performed using SPSS ver. 14.0 (Chicago, Illinois, USA). All data are given as means&#x02009;&#x000b1;&#x02009;standard deviations. The chi-square test and the Mann&#x02013;Whitney test were used for comparisons, as appropriate. For all tests, a two-sided <italic>p</italic>-value less than 0.05 was considered significant. Hazard ratios (HR) and 95% confidence intervals (CIs) were calculated to assess the significance of differences.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Basic clinical information</title><p>Our study cohort consisted of 200 patients with non-thymomatous MG who were treated by extended thymectomy (Table <xref ref-type="table" rid="T1">1</xref>). There were 98 males and 102 females, the mean age was 30.7&#x02009;&#x000b1;&#x02009;12.3 years (range, 15&#x02013;69 years; median, 27.2 years), and the mean duration of symptoms was 1.72&#x02009;&#x000b1;&#x02009;0.21 years (range, 0.5-23 years; median, 1 year). A total of 84 patients were MGFA stage I, 74 were stage IIa, 32 were stage IIb, and 10 were stage IIIa.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><bold>Clinical and demographic characteristics </bold><bold>of the flurbiprofen and </bold><bold>control (tramadol) groups </bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center"><bold>Characteristic</bold></th><th align="center"><bold>Flurbiprofen</bold></th><th align="center"><bold>Control (tramadol)</bold></th><th align="center"><bold><italic>p</italic></bold><bold>value*</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>n</italic><hr/></td><td align="center" valign="bottom">110<hr/></td><td align="center" valign="bottom">90<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Male/female, <italic>n</italic> (%)<hr/></td><td align="center" valign="bottom">59 (53.6)/51 (46.4)<hr/></td><td align="center" valign="bottom">43 (47.8)/47 (52.2)<hr/></td><td align="center" valign="bottom">0.504<hr/></td></tr><tr><td align="left" valign="bottom">Age at surgery, years<hr/></td><td align="center" valign="bottom">31.1&#x02009;&#x000b1;&#x02009;11.8<hr/></td><td align="center" valign="bottom">30.3&#x02009;&#x000b1;&#x02009;13.1<hr/></td><td align="center" valign="bottom">0.691<hr/></td></tr><tr><td align="left" valign="bottom">Mean disease duration, years<hr/></td><td align="center" valign="bottom">1.5&#x02009;&#x000b1;&#x02009;0.8<hr/></td><td align="center" valign="bottom">1.8&#x02009;&#x000b1;&#x02009;0.9<hr/></td><td align="center" valign="bottom">0.401<hr/></td></tr><tr><td align="left" valign="bottom">With/without medulla symptoms, <italic>n</italic> (%)<hr/></td><td align="center" valign="bottom">17 (15.5)/93 (84.5)<hr/></td><td align="center" valign="bottom">15 (16.7)/75 (83.3)<hr/></td><td align="center" valign="bottom">0.816<hr/></td></tr><tr><td align="left" valign="bottom">MGFA stage, <italic>n</italic> (%)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.954<hr/></td></tr><tr><td align="left" valign="bottom">I<hr/></td><td align="center" valign="bottom">46 (41.8)<hr/></td><td align="center" valign="bottom">38 (42.2)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIa<hr/></td><td align="center" valign="bottom">41 (37.3)<hr/></td><td align="center" valign="bottom">33 (36.7)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIb<hr/></td><td align="center" valign="bottom">17 (15.5)<hr/></td><td align="center" valign="bottom">15 (16.7)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIIa<hr/></td><td align="center" valign="bottom">6 (5.45)<hr/></td><td align="center" valign="bottom">4 (4.44)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Time of operation (min)<hr/></td><td align="center" valign="bottom">111.8&#x02009;&#x000b1;&#x02009;25.4<hr/></td><td align="center" valign="bottom">116.4&#x02009;&#x000b1;&#x02009;24.0<hr/></td><td align="center" valign="bottom">0.843<hr/></td></tr><tr><td align="left" valign="bottom">Time of chest drainage (d)<hr/></td><td align="center" valign="bottom">2.7&#x02009;&#x000b1;&#x02009;0.5<hr/></td><td align="center" valign="bottom">2.4&#x02009;&#x000b1;&#x02009;0.8<hr/></td><td align="center" valign="bottom">0.927<hr/></td></tr><tr><td align="left" valign="bottom">Myasthenia crisis<hr/></td><td align="center" valign="bottom">4 (3.6)<hr/></td><td align="center" valign="bottom">3 (3.3)<hr/></td><td align="center" valign="bottom">0.911<hr/></td></tr><tr><td align="left" valign="bottom">MGFA stage at 72 h after operation, <italic>n</italic> (%)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.931<hr/></td></tr><tr><td align="left" valign="bottom">I<hr/></td><td align="center" valign="bottom">47 (42.7)<hr/></td><td align="center" valign="bottom">39 (43.3)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIa<hr/></td><td align="center" valign="bottom">42 (38.2)<hr/></td><td align="center" valign="bottom">33 (36.7)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIb<hr/></td><td align="center" valign="bottom">15 (13.6)<hr/></td><td align="center" valign="bottom">14 (15.6)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">IIIa<hr/></td><td align="center" valign="bottom">6 (5.45)<hr/></td><td align="center" valign="bottom">4 (4.44)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Adverse reactions<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">Nausea and vomiting<hr/></td><td align="center" valign="bottom">14 (12.7)<hr/></td><td align="center" valign="bottom">26 (28.9)<hr/></td><td align="center" valign="bottom">0.021<hr/></td></tr><tr><td align="left" valign="bottom">Headache<hr/></td><td align="center" valign="bottom">5 (4.5)<hr/></td><td align="center" valign="bottom">9 (10.0)<hr/></td><td align="center" valign="bottom">0.162<hr/></td></tr><tr><td align="left">Facial flushing</td><td align="center">3 (2.7)</td><td align="center">4 (4.4)</td><td align="center">0.526</td></tr></tbody></table><table-wrap-foot><p>Values are given as median&#x02009;&#x000b1;&#x02009;SD or (percentage). MGFA, Myasthenia Gravis Foundation Association.</p><p>* <italic>p</italic>-values were calculated by the <italic>&#x003c7;</italic><sup>2</sup> test.</p></table-wrap-foot></table-wrap><p>A total of 110 patients were randomized to the flurbiprofen group and 90 patients to the control (tramadol) group. After surgery, seven cases of myasthenic crisis were recorded, with four cases in the flurbiprofen group (two cases with stage IIb and two cases with stage IIIa), and three cases in the control group (one case with stage IIb and two cases with stage IIIa). Nausea and vomiting were significantly more common in the control group (28.9% <italic>vs.</italic> 12.7%, <italic>p</italic>&#x02009;=&#x02009;0.021), but there were no other significant differences between the flurbiprofen and control groups.</p></sec><sec><title>Assessment of postoperative pain</title><p>Before analgesic administration, patients in both groups complained of wound pain, difficulty with deep breathing, and coughing, and all patients had VAS pain scores of 7 or higher. Our results indicate that both drugs significantly alleviated postoperative pain and that the mean VAS pain score was significantly lower in the flurbiprofen group at 0.5 h, 2 h, 4 h, and 8 h after surgery (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Figure <xref ref-type="fig" rid="F1">1</xref>). There were no differences between the two groups in heart rate (Figure <xref ref-type="fig" rid="F2">2</xref>A), respiratory rate (Figure <xref ref-type="fig" rid="F2">2</xref>B), mean arterial blood pressure (Figure <xref ref-type="fig" rid="F2">2</xref>C), or oxygen saturation (Figure <xref ref-type="fig" rid="F2">2</xref>D) for up to 24 h after surgery.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Comparison of visual analog</bold><bold>pain scores in the</bold><bold>flurbiprofen and control groups</bold><bold>.</bold> An asterisk indicates a significant difference (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></caption><graphic xlink:href="1749-8090-7-98-1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>A, Comparison of heart</bold><bold>beat variation in the</bold><bold>flurbiprofen and control groups;</bold><bold>B, Comparison of respiratory</bold><bold>rate variation in the</bold><bold>flurbiprofen and control groups;</bold><bold>C, Comparison of mean</bold><bold>arterial blood pressure variation</bold><bold>in the flurbiprofen and</bold><bold>control groups; D, Comparison</bold><bold>of variation in blood</bold><bold>oxygen saturation in the</bold><bold>flurbiprofen and control groups.</bold></p></caption><graphic xlink:href="1749-8090-7-98-2"/></fig></sec><sec><title>Adverse reactions</title><p>Nausea and vomiting were significantly more common in the control group than in the flurbiprofen group (12.7% <italic>vs.</italic> 28.9%, <italic>p</italic>&#x02009;=&#x02009;0.021, Table <xref ref-type="table" rid="T1">1</xref>). At 30 min after initiation of analgesia, there were no adverse reactions in either group. In the flurbiprofen group, there 14 cases of nausea and vomiting at 2 h, (6 cases with scores of 3, 8 cases with scores of 2), 9 cases of nausea and vomiting at 4 h, and 5 cases of nausea and vomiting at 8 h. In the control group, there were 26 cases of nausea and vomiting at 2 h (12 cases with scores of 3, 14 cases with scores of 2), and 16 cases of nausea and vomiting at 4 h and 8 h.</p><p>At 2 h after drug injection, five cases in flurbiprofen group and nine cases in control group had headaches, but all of these patients experienced remission at 4 h. Remarkably, three cases in the flurbiprofen group and four cases in the control (tramadol) group had facial flushing at 2 h after drug injection, and these symptoms remained for 24 h in all patients.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Extended thymectomy is recognized worldwide as an important technique to manage myasthenia gravis, and median sternotomy is the major surgical method [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. The injury caused by this surgery is considerable, because the pleura are often damaged during resection of anterior mediastinal fat tissue. Surgery may lead to hemothorax or pleural effusion that can affect pulmonary re-expansion. Coughing, sputum expulsion, and initiation of deep breathing are important measures that promote lung re-expansion and reduce the risk of pulmonary infection. The surgical pain of such patients typically has medium-to-high intensity, and may inhibit breathing, coughing, and sputum expulsion, thereby disrupting postoperative recovery, increasing the risk of pulmonary atelectasis and infection, and even induce myasthenic crisis [<xref ref-type="bibr" rid="B30">30</xref>]. Our previous study of MG patients demonstrated that the serum concentration of immunoglobulin G was high after thymectomy [<xref ref-type="bibr" rid="B31">31</xref>]. Another report showed that the levels of serum CRP, IL-6, and TNF-&#x003b1; were elevated after thoracotomy [<xref ref-type="bibr" rid="B26">26</xref>]. Together, these findings indicate significant inflammation after thymectomy, suggesting that an anti-inflammatory agent such as flurbiprofen may be effective in reducing this inflammation.</p><p>Common analgesics, such as tramadol and adolens, are often not recommended for MG patients because they can depress respiration and are associated adverse effects (nausea, vomiting, irritability) that can increase the risk of a myasthenic crisis or worsen postoperative conditions. Therefore, an effective analgesic is needed that allows pain-free recovery from thymectomy but does not inhibit the respiratory muscles.</p><p>Flurbiprofen axetil (2-[3-fluoro-4-biphenyl] propanoic acid) is an NSAID of the propionic acid class and tablets are approved for relief of pain from rheumatoid arthritis and osteoarthritis [<xref ref-type="bibr" rid="B32">32</xref>]. Intravenous flurbiprofen axetil is provided as 50 mg ampoules and selectively accumulates at the surgical incision and inflammation sites after administration. Flurbiprofen axetil is mostly metabolized into flurbiprofen by hydrolysis and its analgesic effect is believed to result from the reversible inhibition of cyclooxygenase and peripheral inhibition of prostaglandin synthesis. Analgesia has been reported to last for up to 24 h after intravenous administration [<xref ref-type="bibr" rid="B33">33</xref>]. During postoperative pain management with flurbiprofen, patients must be monitored for side effects, especially gastrointestinal effects, as with all NSAIDs [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Previous studies have reported that use of flurbiprofen for postoperative analgesia in anesthesia, general surgery, obstetrics and gynecology, and orthopedics was effective and safe, had little effect on respiration, and prolonged the duration of analgesia [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B38">38</xref>]. However, there have been no reports on the use of flurbiprofen following thoracic surgery or in patients with MG following extended thymectomy.</p><p>Our results indicate that intravenous flurbiprofen axetil can effectively reduce post-thymectomy pain without disruption of respiratory rate, heart rate, or blood pressure. The analgesic effect lasted for up to 24 h for most patients. There was no significant difference in the incidence of myasthenic crisis in the flurbiprofen and control groups and there were fewer adverse effects in the flurbiprofen group. The most common adverse effects following flurbiprofen axetil were headache, vomiting, and flushing. Mild symptoms resolved by themselves within 3 days, and there were more cases of adverse reactions in the control group. Slow intravenous administration of flurbiprofen allows immediate withdrawal if respiratory inhibition occurs and provides an extended duration of analgesia.</p><p>This study confirms that flurbiprofen axetil is a safe and effective analgesic for post-thymectomy patients with MG and that it is associated with a lower incidence of adverse reactions than tramadol. Thus, slow intravenous administration of flurbiprofen axetil is safe for clinical use and is not associated with respiratory inhibition.</p></sec><sec><title>Competing interests</title><p>The authors declare no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>CS and ZC designed the study, collected data, and drafted the manuscript. CC performed the statistical analysis and drafted the manuscript. YS, YL, JZ, BZ participated in data collection. HL participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Drachman</surname><given-names>DB</given-names></name><article-title>Myasthenia gravis</article-title><source>N Engl J Med</source><year>1994</year><volume>330</volume><fpage>1797</fpage><lpage>1810</lpage><pub-id pub-id-type="doi">10.1056/NEJM199406233302507</pub-id><pub-id pub-id-type="pmid">8190158</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Hughes</surname><given-names>BW</given-names></name><name><surname>Moro De Casillas</surname><given-names>ML</given-names></name><name><surname>Kaminski</surname><given-names>HJ</given-names></name><article-title>Pathophysiology of myasthenia gravis</article-title><source>Semin Neurol</source><year>2004</year><volume>24</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1055/s-2004-829585</pub-id><pub-id pub-id-type="pmid">15229789</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Masaoka</surname><given-names>A</given-names></name><article-title>Extended trans-sternal thymectomy for myasthenia gravis</article-title><source>Chest Surg Clin N Am</source><year>2001</year><volume>11</volume><fpage>369</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">11413762</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Oosterhuis</surname><given-names>HJ</given-names></name><article-title>Thymectomy in myasthenia gravis. A review</article-title><source>Ital J Neurol Sci</source><year>1983</year><volume>4</volume><fpage>399</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1007/BF02125618</pub-id><pub-id pub-id-type="pmid">6370908</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Nussbaum</surname><given-names>MS</given-names></name><name><surname>Rosenthal</surname><given-names>GJ</given-names></name><name><surname>Samaha</surname><given-names>FJ</given-names></name><name><surname>Grinvalsky</surname><given-names>HT</given-names></name><name><surname>Quinlan</surname><given-names>JG</given-names></name><name><surname>Schmerler</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>JE</given-names></name><article-title>Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection</article-title><source>Surgery</source><year>1992</year><volume>112</volume><fpage>681</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">1411938</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Frist</surname><given-names>WH</given-names></name><name><surname>Thirumalai</surname><given-names>S</given-names></name><name><surname>Doehring</surname><given-names>CB</given-names></name><name><surname>Merrill</surname><given-names>WH</given-names></name><name><surname>Stewart</surname><given-names>JR</given-names></name><name><surname>Fenichel</surname><given-names>GM</given-names></name><name><surname>Bender</surname><given-names>HW</given-names><suffix>Jr</suffix></name><article-title>Thymectomy for the myasthenia gravis patient: factors influencing outcome</article-title><source>Ann Thor Surg</source><year>1994</year><volume>57</volume><fpage>334</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(94)90993-8</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Itoyama</surname><given-names>Y</given-names></name><name><surname>Machi</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>I</given-names></name><article-title>Analysis of prognostic factors in thymectomized patients with myasthenia gravis: correlation between thymic lymphoid cell subsets and postoperative clinical course</article-title><source>J Neurol Sci</source><year>1991</year><volume>105</volume><issue>2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(91)90137-V</pub-id><pub-id pub-id-type="pmid">1721934</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Masaoka</surname><given-names>A</given-names></name><name><surname>Yamakawa</surname><given-names>Y</given-names></name><name><surname>Niwa</surname><given-names>H</given-names></name><name><surname>Fukai</surname><given-names>I</given-names></name><name><surname>Condo</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Monden</surname><given-names>Y</given-names></name><article-title>Extended thymectomy for myasthenia gravis: a 20 year review</article-title><source>Ann Thor Surg</source><year>1996</year><volume>62</volume><fpage>853</fpage><lpage>859</lpage><comment>Sept</comment><pub-id pub-id-type="doi">10.1016/S0003-4975(96)00376-1</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Detterbeck</surname><given-names>FC</given-names></name><name><surname>Scott</surname><given-names>WW</given-names></name><name><surname>Howard</surname><given-names>JF</given-names></name><name><surname>Egan</surname><given-names>TM</given-names></name><name><surname>Keagy</surname><given-names>BA</given-names></name><name><surname>Starek</surname><given-names>JK</given-names></name><name><surname>Mill</surname><given-names>MR</given-names></name><name><surname>Wilcox</surname><given-names>BR</given-names></name><article-title>One hundred consecutive thymectomies for myasthenia gravis</article-title><source>Ann Thorac Surg</source><year>1996</year><volume>62</volume><fpage>242</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(96)00202-0</pub-id><pub-id pub-id-type="pmid">8678650</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="book"><name><surname>Mack</surname><given-names>MJ</given-names></name><name><surname>Scruggs</surname><given-names>GR</given-names></name><person-group person-group-type="editor">Shields T, LoCicero J, Ponn R</person-group><article-title>Video-assisted thymectomy</article-title><source>General thoracic surgery</source><year>2000</year><edition>5</edition><publisher-name>Philadelphia, PA: Lippincott Williams &#x00026; Wilkins</publisher-name><fpage>2243</fpage><lpage>2249</lpage><comment>2 Section XXVIII, Chapter 173</comment></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Mineo</surname><given-names>TC</given-names></name><name><surname>Pompeo</surname><given-names>E</given-names></name><name><surname>Ambrogi</surname><given-names>V</given-names></name><name><surname>Sabato</surname><given-names>AF</given-names></name><name><surname>Bernardi</surname><given-names>G</given-names></name><name><surname>Casciani</surname><given-names>CU</given-names></name><article-title>Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis</article-title><source>Ann Thor Surg</source><year>1996</year><volume>62</volume><fpage>1210</fpage><lpage>1212</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(96)00537-1</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Shrager</surname><given-names>JB</given-names></name><name><surname>Deeb</surname><given-names>ME</given-names></name><name><surname>Mick</surname><given-names>R</given-names></name><name><surname>Brinster</surname><given-names>CJ</given-names></name><name><surname>Childers</surname><given-names>HE</given-names></name><name><surname>Marshall</surname><given-names>MB</given-names></name><name><surname>Kucharczuk</surname><given-names>JC</given-names></name><name><surname>Galetta</surname><given-names>SL</given-names></name><name><surname>Bird</surname><given-names>SJ</given-names></name><name><surname>Kaiser</surname><given-names>LR</given-names></name><article-title>Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(02)03722-0</pub-id><pub-id pub-id-type="pmid">12173807</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Lindberg</surname><given-names>C</given-names></name><name><surname>Andersen</surname><given-names>O</given-names></name><name><surname>Larsson</surname><given-names>S</given-names></name><name><surname>Oden</surname><given-names>A</given-names></name><article-title>Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated</article-title><source>Acta Neurol Scand</source><year>1992</year><volume>86</volume><issue>3</issue><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0404.1992.tb05094.x</pub-id><pub-id pub-id-type="pmid">1414255</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Jaretzki</surname><given-names>A</given-names><suffix>III</suffix></name><name><surname>Penn</surname><given-names>AS</given-names></name><name><surname>Younger</surname><given-names>DS</given-names></name><name><surname>Wolff</surname><given-names>M</given-names></name><name><surname>Olarte</surname><given-names>MR</given-names></name><name><surname>Lovelace</surname><given-names>RE</given-names></name><name><surname>Rowland</surname><given-names>LP</given-names></name><article-title>&#x0201c;Maximal&#x0201d; thymectomy for myasthenia gravis: results</article-title><source>J Thorac Cardiovasc Surg</source><year>1988</year><volume>95</volume><fpage>747</fpage><lpage>757</lpage><pub-id pub-id-type="pmid">3361927</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Kalso</surname><given-names>E</given-names></name><name><surname>Mennander</surname><given-names>S</given-names></name><name><surname>Tasmuth</surname><given-names>T</given-names></name><name><surname>Nilsson</surname><given-names>E</given-names></name><article-title>Chronic post-sternotomy pain</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>935</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.450803.x</pub-id><pub-id pub-id-type="pmid">11576042</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Meyerson</surname><given-names>J</given-names></name><name><surname>Thelin</surname><given-names>S</given-names></name><name><surname>Gordh</surname><given-names>T</given-names></name><name><surname>Karlsten</surname><given-names>R</given-names></name><article-title>The incidence of chronic post-sternotomy pain after cardiac surgery&#x02013;a prospective study</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>940</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.450804.x</pub-id><pub-id pub-id-type="pmid">11576043</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Abel</surname><given-names>M</given-names></name><name><surname>Eisenkraft</surname><given-names>JB</given-names></name><article-title>Anesthetic implications of myasthenia gravis</article-title><source>Mt Sinai J Med</source><year>2002</year><volume>69</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11832968</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Ferreti</surname><given-names>F</given-names></name><name><surname>Crestan</surname><given-names>IS</given-names></name><name><surname>Rudriguez</surname><given-names>NJ</given-names></name><name><surname>Tosi</surname><given-names>C</given-names></name><name><surname>Martinoli</surname><given-names>S</given-names></name><article-title>Can one use high thoracic epidural analgesia in post operative intensive care of the myasthenia patient following trans sternal thymectomy?</article-title><source>Schweiz Med Woehenschr</source><year>1987</year><volume>117</volume><fpage>438</fpage><lpage>441</lpage></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Nilsson</surname><given-names>E</given-names></name><name><surname>Perttunen</surname><given-names>K</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name><article-title>Intrathecal morphine for post-sternotomy pain in patients with myasthenia gravis: effects on respiratory function</article-title><source>Acta Anaesthesiol Scand</source><year>1997</year><volume>41</volume><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.1997.tb04743.x</pub-id><pub-id pub-id-type="pmid">9181154</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Hopkins</surname><given-names>D</given-names></name><name><surname>Shipton</surname><given-names>EA</given-names></name><name><surname>Potgieter</surname><given-names>D</given-names></name><name><surname>CA</surname><given-names>VdM</given-names></name><name><surname>Boon</surname><given-names>J</given-names></name><name><surname>De Wet</surname><given-names>C</given-names></name><name><surname>Murphy</surname><given-names>J</given-names></name><article-title>Comparison of tramadol and morphine via subcutaneous PCA following major orthopaedic surgery</article-title><source>Can J Anaesth</source><year>1998</year><volume>45</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1007/BF03012579</pub-id><pub-id pub-id-type="pmid">9598258</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Haroutiunian</surname><given-names>S</given-names></name><name><surname>Lecht</surname><given-names>S</given-names></name><name><surname>Zur</surname><given-names>AA</given-names></name><name><surname>Hoffman</surname><given-names>A</given-names></name><name><surname>Davidson</surname><given-names>E</given-names></name><article-title>The challenge of pain management in patients with myasthenia gravis</article-title><source>J Pain Palliat Care Pharmacother</source><year>2009</year><volume>23</volume><fpage>242</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1080/15360280903098523</pub-id><pub-id pub-id-type="pmid">19670021</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Perttunen</surname><given-names>K</given-names></name><name><surname>Nilsson</surname><given-names>E</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name><article-title>I.v. diclofenac and ketorolac for pain after thoracoscopic surgery</article-title><source>Br J Anaesth</source><year>1999</year><volume>82</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1093/bja/82.2.221</pub-id><pub-id pub-id-type="pmid">10364998</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Tarkkila</surname><given-names>P</given-names></name><name><surname>Saarnivaara</surname><given-names>L</given-names></name><article-title>Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults?</article-title><source>Br J Anaesth</source><year>1999</year><volume>82</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/bja/82.1.56</pub-id><pub-id pub-id-type="pmid">10325837</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Mikawa</surname><given-names>K</given-names></name><name><surname>Nishina</surname><given-names>K</given-names></name><name><surname>Maekawa</surname><given-names>N</given-names></name><name><surname>Shiga</surname><given-names>M</given-names></name><name><surname>Obara</surname><given-names>H</given-names></name><article-title>Dose&#x02013;response of flurbiprofen on postoperative pain and emesis after paediatric strabismus surgery</article-title><source>Can J Anaesth</source><year>1997</year><volume>44</volume><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/BF03014332</pub-id><pub-id pub-id-type="pmid">8988832</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Ottinger</surname><given-names>ML</given-names></name><name><surname>Kinney</surname><given-names>KW</given-names></name><name><surname>Black</surname><given-names>JR</given-names></name><name><surname>Wittenberg</surname><given-names>M</given-names></name><article-title>Comparison of flurbiprofen and acetaminophen with codeine in postoperative foot pain</article-title><source>J Am Podiatr Med Assoc</source><year>1990</year><volume>80</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">2366172</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Esme</surname><given-names>H</given-names></name><name><surname>Kesli</surname><given-names>R</given-names></name><name><surname>Apiliogullari</surname><given-names>B</given-names></name><name><surname>Duran</surname><given-names>FM</given-names></name><name><surname>Yoldas</surname><given-names>B</given-names></name><article-title>Effects of flurbiprofen on CRP, TNF-&#x003b1;, IL-6, and postoperative pain of thoracotomy</article-title><source>Int J Med Sci</source><year>2011</year><volume>8</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">21448308</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Budde</surname><given-names>JM</given-names></name><name><surname>Morris</surname><given-names>CD</given-names></name><name><surname>Gal</surname><given-names>AA</given-names></name><name><surname>Manosur</surname><given-names>KA</given-names></name><name><surname>Miller</surname><given-names>JI</given-names></name><article-title>Predictor of outcome in thymectomy for myasthenia gravis</article-title><source>Ann Thorac Surg</source><year>2001</year><volume>72</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(01)02678-9</pub-id><pub-id pub-id-type="pmid">11465178</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="book"><name><surname>Osserman</surname><given-names>KE</given-names></name><source>Myasthenia gravis</source><year>1958</year><publisher-name>Grune and Stratton: New York</publisher-name></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Bulkley</surname><given-names>GB</given-names></name><name><surname>Bass</surname><given-names>KN</given-names></name><name><surname>Stephenson</surname><given-names>GR</given-names></name><name><surname>Diener-West</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Reilly</surname><given-names>PA</given-names></name><name><surname>Baker</surname><given-names>RR</given-names></name><name><surname>Drachman</surname><given-names>DB</given-names></name><article-title>Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis</article-title><source>Ann Surg</source><year>1997</year><volume>226</volume><fpage>324</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1097/00000658-199709000-00012</pub-id><pub-id pub-id-type="pmid">9339939</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Massard</surname><given-names>G</given-names></name><name><surname>Wihlm</surname><given-names>JM</given-names></name><article-title>Postoperative atelectasis</article-title><source>Chest Surg Clin N Am</source><year>1998</year><volume>8</volume><fpage>503</fpage><lpage>528</lpage><comment>viii</comment><pub-id pub-id-type="pmid">9742334</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>ZG</given-names></name><name><surname>Luo</surname><given-names>HH</given-names></name><name><surname>Peng</surname><given-names>YW</given-names></name><name><surname>Cai</surname><given-names>LE</given-names></name><name><surname>Zhang</surname><given-names>JL</given-names></name><name><surname>Su</surname><given-names>CH</given-names></name><name><surname>Zou</surname><given-names>JY</given-names></name><article-title>Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus</article-title><source>Ann Thorac Surg</source><year>2011</year><volume>91</volume><fpage>212</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.08.041</pub-id><pub-id pub-id-type="pmid">21172515</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Lomen</surname><given-names>PL</given-names></name><name><surname>Samal</surname><given-names>BA</given-names></name><name><surname>Lamborn</surname><given-names>KR</given-names></name><name><surname>Sattler</surname><given-names>LP</given-names></name><name><surname>Crampton</surname><given-names>SL</given-names></name><article-title>Flurbiprofen for the treatment of bone pain in patients with metastatic breast cancer</article-title><source>Am J Med</source><year>1986</year><volume>80</volume><issue>3A</issue><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">3515928</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="other"><name><surname>Sultan</surname><given-names>A</given-names></name><name><surname>McQuay</surname><given-names>HJ</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Derry</surname><given-names>S</given-names></name><article-title>Single dose oral flurbiprofen for acute postoperative pain in adults</article-title><source>Cochrane Database of Systematic Reviews</source><year>2009, (3)</year><comment>Art. No.: CD007358</comment><comment>0.1002/14651858.CD007358.pub2</comment></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Roszkowski</surname><given-names>MT</given-names></name><name><surname>Swift</surname><given-names>JQ</given-names></name><name><surname>Hargreaves</surname><given-names>KM</given-names></name><article-title>Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars</article-title><source>Pain</source><year>1997</year><volume>73</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(97)00120-6</pub-id><pub-id pub-id-type="pmid">9469523</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Swift</surname><given-names>JQ</given-names></name><name><surname>Garry</surname><given-names>MG</given-names></name><name><surname>Roszkowski</surname><given-names>MT</given-names></name><name><surname>Hargreaves</surname><given-names>KM</given-names></name><article-title>Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain</article-title><source>J Oral Maxillofac Surg</source><year>1993</year><volume>51</volume><fpage>112</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/S0278-2391(10)80002-3</pub-id><pub-id pub-id-type="pmid">8426248</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Troullos</surname><given-names>ES</given-names></name><name><surname>Hargreaves</surname><given-names>KM</given-names></name><name><surname>Butler</surname><given-names>DP</given-names></name><name><surname>Dionne</surname><given-names>RA</given-names></name><article-title>Comparison of nonsteroidal anti-inflammatory drugs, ibuprofen and flurbiprofen, with methylprednisolone and placebo for acute pain, swelling, and trismus</article-title><source>J Oral Maxillofac Surg</source><year>1990</year><volume>48</volume><fpage>945</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1016/0278-2391(90)90007-O</pub-id><pub-id pub-id-type="pmid">2395047</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Sisk</surname><given-names>AL</given-names></name><name><surname>Bonnington</surname><given-names>GJ</given-names></name><article-title>Evaluation of methylprednisolone and flurbiprofen for inhibition of the postoperative inflammatory response</article-title><source>Oral Surg Oral Med Oral Pathol</source><year>1985</year><volume>60</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/0030-4220(85)90281-6</pub-id><pub-id pub-id-type="pmid">3862020</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Dionne</surname><given-names>RA</given-names></name><name><surname>Wirdzek</surname><given-names>PR</given-names></name><name><surname>Fox</surname><given-names>PC</given-names></name><name><surname>Dubner</surname><given-names>R</given-names></name><article-title>Suppression of postoperative pain by the combination of a nonsteroidal anti-inflammatory drug, flurbiprofen, and a long-acting local anesthetic, etidocaine</article-title><source>J Am Dent Assoc</source><year>1984</year><volume>108</volume><fpage>598</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">6586802</pub-id></mixed-citation></ref></ref-list></back></article>